Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $29.5600 (-1.79%) ($29.3600 - $30.5230) on Tue. Nov. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 57 | Latest Price | $29.5600(-1.79%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | TGTX advances 2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(64%) ARKG(59%) ARKK(56%) IWO(56%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -1.645% in a week (0% probabilities). VIXM(-37%) VXX(-34%) UUP(-19%) EDOC(-3%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $29.86(-1%) | 10 Day Moving Average | $29.3(0.89%) | 20 Day Moving Average | $28.37(4.19%) | To recent high | -5% | To recent low | 28% | Market Cap | $3.744b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |